1. Resistance to thyroid hormone is modulated in vivo by the nuclear receptor corepressor (NCOR1)Mutations in the ligand-binding domain of TRbeta lead to resistance to thyroid hormone (RTH). These TRbeta mutants function in a dominant negative fashion to interfere with the transcription activity of wild-type TRs, leading to dys-regulation of the pituitary-thyroid axis and resistance in peripheral tissues. The molecular mechanism by which TRbeta mutants cause RTH has been postulated to be an inability of the mutants to properly release the nuclear corepressors (NCORs), thereby inhibiting thyroid hormone TRbetaPV mice that is a model of RTH, expressing a human TRbeta mutant (PV), with mice expressing a mutant Ncor1 allele (Ncor1deltaID mice) that cannot recruit TR or PV mutant. Remarkably, in the presence of NCOR1deltaID, the abnormally elevated TSH and TH levels found in TRbetaPV mice were modestly but significantly corrected. Furthermore, thyroid hyperplasia, weight loss, and other hallmarks of RTH, were also partially reverted in mice expressing NCOR1deltaID. Taken together, these data suggest that the aberrant recruitment of NCOR1 by RTH TRbeta mutants leads to clinical RTH in humans. The present study suggests that therapies aimed at the TR-NCOR1 interaction or its downstream actions could be tested as potential targets in treating RTH.2. Activation of Wnt/beta-catenin signaling in the skeleton of mice with advanced bone formation due to a dominant-negative mutation in the thyroid hormone receptor beta geneThyroid hormone (T3) acts in chondrocytes and bone-forming osteoblasts to control bone development and maintenance but the signaling pathways mediating these effects are poorly understood. TRbetaPV/PV mice have a severely impaired pituitary-thyroid axis and elevated thyroid hormone levels due to a dominant-negative mutant TRbeta (TRbetaPV) that cannot bind T3 and interferes with the actions of wild-type TR. TRbetaPV/PV mice have accelerated skeletal development due to unknown mechanisms. We performed microarray studies in primary osteoblasts from wild-type mice and TRbetaPV/PV mice. Activation of the canonical Wnt signaling in TRbetaPV/PV mice was confirmed by in situ hybridization analysis of Wnt target gene expression in bone during post-natal growth. By contrast, T3 treatment increased phosphorylation of beta-catenin and inhibited Wnt signaling in osteoblastic cells, indicating T3 inhibits the Wnt pathway by facilitating proteasomal degradation of beta-catenin and preventing its accumulation in the nucleus. Activation of the Wnt pathway in TRbetaPV/PV mice, however, suggests a gain-of-function for TRbetaPV that stabilizes beta-catenin despite the presence of increased thyroid hormone levels. These studies demonstrate novel interactions between T3 and Wnt signaling pathways in the regulation of skeletal development and bone formation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Investigator-Initiated Intramural Research Projects (ZIA)
Project #
1ZIABC008752-32
Application #
8552604
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
32
Fiscal Year
2012
Total Cost
$716,979
Indirect Cost
Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
Zip Code
Milanesi, Anna; Lee, Jang-Won; Kim, Nam-Ho et al. (2016) Thyroid Hormone Receptor α Plays an Essential Role in Male Skeletal Muscle Myoblast Proliferation, Differentiation, and Response to Injury. Endocrinology 157:4-15
Sayre, Naomi L; Sifuentes, Mikaela; Holstein, Deborah et al. (2016) Stimulation of astrocyte fatty acid oxidation by thyroid hormone is protective against ischemic stroke-induced damage. J Cereb Blood Flow Metab :
Zhu, Xuguang; Kim, Dong Wook; Zhao, Li et al. (2016) SAHA-induced loss of tumor suppressor Pten gene promotes thyroid carcinogenesis in a mouse model. Endocr Relat Cancer 23:521-33
Lee, Min Hee; Lee, Jung Uee; Joung, Kyong Hye et al. (2015) Thyroid dysfunction associated with follicular cell steatosis in obese male mice and humans. Endocrinology 156:1181-93
Alamino, Vanina A; Mascanfroni, Iván D; Montesinos, María M et al. (2015) Antitumor Responses Stimulated by Dendritic Cells Are Improved by Triiodothyronine Binding to the Thyroid Hormone Receptor β. Cancer Res 75:1265-74
Cheng, Sheue-yann (2015) My journey to unravel complex actions of thyroid hormone: was it fate or destiny? Endocr Relat Cancer 22:P1-P10
Park, Jeong Won; Zhao, Li; Willingham, Mark et al. (2015) Oncogenic mutations of thyroid hormone receptor β. Oncotarget 6:8115-31
Bassett, J H Duncan; Boyde, Alan; Zikmund, Tomas et al. (2014) Thyroid Hormone Receptor * Mutation Causes a Severe and Thyroxine-Resistant Skeletal Dysplasia in Female Mice. Endocrinology 155:3699-712
Kim, Dong Wook; Park, Jeong Won; Willingham, Mark C et al. (2014) A histone deacetylase inhibitor improves hypothyroidism caused by a TR*1 mutant. Hum Mol Genet 23:2651-64
Kim, Won Gu; Zhao, Li; Kim, Dong Wook et al. (2014) Inhibition of tumorigenesis by the thyroid hormone receptor * in xenograft models. Thyroid 24:260-9

Showing the most recent 10 out of 36 publications